Andy Morley
Investitore di Private Equity presso o2h Ltd
Profilo
Andy Morley is currently employed as a Principal at o2h Ltd and as a CSO at Opal Therapeutics Ltd.
He graduated from the University of Salford in 1990 with a graduate degree and also attended Nagoya University where he earned a graduate degree.
Posizioni attive di Andy Morley
| Società | Posizione | Inizio |
|---|---|---|
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investitore di Private Equity | 01/01/2013 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01/06/2012 |
Formazione di Andy Morley
| University of Salford | Graduate Degree |
| Nagoya University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Andy Morley
